COVID-19

Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders

Postmortem Neuropathology in COVID-19

For November 2020, we have selected: Agarwal P. et al. Neurological manifestations in 404 COVID‑19 patients in Washington State. J Neurol 2020 Aug 6;1-3. doi: 10.1007/s00415-020-10087-z. Online ahead of print.

EJoN publishes EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic

Newest addition to Breaking News submitted by Neurooncology Panel: Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas

Newest contribution to Breaking News is by Dementia Panel: Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID-19 pandemic, now and in the future

COVID-19 in Parkinson's disease: Report on prevalence and outcome

Clinical and neuroimaging correlation in patients with COVID-19

The effect of the COVID-19 pandemic on people with Parkinson's disease

SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?

Electroencephalographic findings in COVID-19 patients: A systematic review

The spectrum of neuropathology in COVID-19

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia

The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership

COVID-19 case fatality and Parkinson’s disease